HomeIMCR • NASDAQ
add
Immunocore Holdings PLC - ADR
Previous close
$29.00
Day range
$27.19 - $29.82
Year range
$27.19 - $66.00
Market cap
1.42B USD
Avg Volume
195.51K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 84.05M | 19.80% |
Operating expense | 232.68M | 19.83% |
Net income | -23.77M | -20.48% |
Net profit margin | -28.28 | -0.57% |
Earnings per share | -0.47 | -17.50% |
EBITDA | -235.00K | 98.61% |
Effective tax rate | 4.23% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 820.38M | 85.34% |
Total assets | 1.01B | 69.10% |
Total liabilities | 648.79M | 184.36% |
Total equity | 360.72M | — |
Shares outstanding | 50.07M | — |
Price to book | 4.03 | — |
Return on assets | -0.33% | — |
Return on capital | -0.42% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -23.77M | -20.48% |
Cash from operations | -13.95M | 21.33% |
Cash from investing | -3.54M | -333.29% |
Cash from financing | -51.51M | -923.65% |
Net change in cash | -82.04M | -5,325.66% |
Free cash flow | -10.20M | -65.73% |
About
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology. Wikipedia
Founded
2008
Website
Employees
493
